Related Experiment Video
Updated: Jan 21, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Association between phase angle and one-year heart failure rehospitalization and all-cause mortality in patients with
Masaya Hori1, Koya Takino2, Takuji Adachi3
1Department of Cardiac Rehabilitation, Gifu Heart Center, Gifu, Japan.
Background & Aims:
Phase angle (PhA) reflects cellular health and nutritional status. Although PhA has been linked to mortality in various populations, its prognostic value for heart failure (HF), especially rehospitalization, remains unclear. This study investigated the association between PhA and the composite outcome of HF rehospitalization and all-cause mortality after discharge in patients hospitalized for acute HF.
Methods:
Patients hospitalized with HF who underwent rehabilitation during hospitalization. The primary outcome was a composite of HF rehospitalization and all-cause mortality within one year. Associations were evaluated with multivariate Cox proportional hazards models. Receiver operating characteristic analysis determined the optimal PhA cut-off. The cumulative incidence of the composite outcome and all-cause mortality were estimated using Kaplan-Meier analysis with log-rank tests. For HF rehospitalization, the cumulative incidence was calculated using Gray's test, with death as a competing risk.
Results:
The one-year incidence of the composite outcome was 23.3 % (n = 97) among the 417 patients. In multivariate models, PhA independently predicted the composite outcome (hazard ratio: 0.74; 95 % confidence interval: 0.55-0.99, p = 0.048). The optimal PhA cut-off was 3.8. Patients with PhA <3.8 had significantly higher rates of HF rehospitalization (p = 0.033), composite outcomes (p = 0.001), and all-cause mortality (p = 0.002).
Conclusions:
In patients with HF, PhA assessed during hospitalization was significantly associated with HF rehospitalization and all-cause mortality within one year. These findings support PhA as a useful biomarker for prognostic assessment in clinical practice.
More Related Videos
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
03:47Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Diuretics
Heart Failure V: Medical Management